Myelodysplastic Syndrome
RareBlood Disorders
Myelodysplastic Syndrome is treated with 8 medications in our database, including Revlimid, AZACITIDINE, Decitabine, DECITABINE, Azacitidine, and 3 more. 8 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Bristol Myers Squibb, Pilnova Pharma Inc, BluePoint Laboratories, Eisai, Celgene and others. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Myelodysplastic Syndrome treatment below.
What help exists for Myelodysplastic Syndrome
13
drugs indexed
6
with copay cards
6
with patient assistance
8
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Myelodysplastic Syndrome
13 totalDeferiprone
deferiprone
ALVAIZ
Eltrombopag Β· Teva Pharmaceuticals
ππGRAFAPEX
treosulfan
ππINQOVI
CEDAZURIDINE and DECITABINE Β· Taiho
AZACITIDINE
AZACITIDINE Β· Pilnova Pharma Inc
ππPROMACTA
eltrombopag olamine
FERRIPROX
deferiprone Β· Chiesi reinforcement _Self-correction:_ The user asked for the primary manufacturer/company that owns the rights. Chiesi is the entity. Final string: Chiesi
VIDAZA
azacitidine Β· Celgene
ππELTROMBOPAG
eltrombopag
Nplate
romiplostim Β· Amgen
ππRevlimid
Lenalidomide
ππEltrombopag Olamine
Eltrombopag Olamine
DECITABINE
Decitabine Β· Eisai
π = copay card Β· π = patient assistance program
Prior authorization patterns for Myelodysplastic Syndrome drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
Showing 10 of 20 PA rules for Myelodysplastic Syndrome drugs. View individual drug pages for complete PA detail.
Grants for Myelodysplastic Syndrome patients
13 total Β· 8 open- open
Bristol Myers Squibb Patient Assistance Program
Bristol-Myers Squibb
Covers: financial assistance
- open
Bristol Myers Squibb Patient Assistance Program
Bristol-Myers Squibb
Covers: financial assistance
- open
Myelodysplastic syndrome medication copay assistance
PAN Foundation
Covers: financial assistance
- open
Bristol Myers Squibb Patient Assistance Program
Bristol-Myers Squibb
Covers: financial assistance
- open
Bristol Myers Squibb Patient Assistance
Bristol-Myers Squibb
Covers: financial assistance
- open
Bristol Myers Squibb Patient Assistance Program
Bristol-Myers Squibb
Covers: financial assistance
- open
Bristol Myers Squibb Patient Assistance Program
Bristol-Myers Squibb
Covers: financial assistance
- open
Bristol Myers Squibb Patient Assistance Program
Bristol-Myers Squibb
Covers: financial assistance
- unknown
BMS Access Support - ONUREG (azacitidine) Patient Assistance Program
Bristol-Myers Squibb
Covers: financial assistance
- unknown
Bristol Myers Squibb Patient Assistance
Bristol-Myers Squibb
Covers: financial assistance
- unknown
Bristol-Myers Squibb Patient Assistance Program Application Form
Bristol-Myers Squibb
Covers: financial assistance
- unknown
Bristol Myers Squibb Patient Assistance Program
Bristol-Myers Squibb
Covers: financial assistance
- unknown
Bristol Myers Squibb Patient Assistance Foundation Application
Bristol Myers Squibb Patient Assistance Foundation
Covers: financial assistance
Myelodysplastic Syndrome is a rare disease β more resources at UniteRare
Our sister site covers specialists, clinical trials, patient communities, and rare-disease-specific diagnosis tools.
Visit UniteRare β